Third strike for BMS Opdivo in brain cancer

Third strike for BMS’ Opdivo in brain cancer

05:59 EDT 6 Sep 2019 | PMLIVE

Despite failing first endpoint, trial is set to continue

Original Article: Third strike for BMS’ Opdivo in brain cancer

More From BioPortfolio on "Third strike for BMS’ Opdivo in brain cancer"